ABSI vs XERS Stock Comparison

XERS currently leads ABSI in this stock comparison, with AIQ scores of 78 vs 53. The clearest difference is quality.

Market data as of Nov 15, 2026 market close· AIQ score gap 25 points
ABSI
Healthcare
vs
XERS
Healthcare
ABSI
Absci Corporation
Price
$8.45
Day move
-7.5%
AIQ Score
53/100
Best edge
Balanced
Sector
Healthcare
XERS
Xeris Biopharma Holdings, Inc.
Leads
Price
$16.66
Day move
+0.06%
AIQ Score
78/100
Best edge
Quality
Sector
Healthcare

What is the main difference between ABSI and XERS?

XERS leads the current stock comparison as Xeris Biopharma Holdings, Inc., with the clearest separation coming from quality and the broader AIQ evidence mix.

AlgovestIQ AIQ Comparison

Absci Corporation vs Xeris Biopharma Holdings, Inc.

Data as of Nov 15, 2026· market close· Healthcare· Coverage 63/66 fields· High confidence
AIQ VerdictStableAIQ Comparison Conviction 9/10

XERS leads

XERS leads by 25 AIQ points, primarily on Quality and Risk Resilience. Wall Street currently favors ABSI on target upside.

Stable: 4 of 5 evidence groups support XERS, and its current signal state is conflicted.

Evidence agreement: 4 of 5Comparison trend: Stable
ABSI

Absci Corporation

AIQ Score
53/100
AIQ Edge Score
9/10
XERS

Xeris Biopharma Holdings, Inc.

Leads
AIQ Score
78/100
AIQ Edge Score
10/10

The Algovestiq AIQ Score currently favors XERS over ABSI, 78 versus 53 as of Nov 15, 2026. XERS's advantage is driven primarily by stronger quality and risk resilience. XERS also shows the stronger technical structure relative to its 50-day moving average, though analyst target upside currently favors ABSI. 4 of 5 covered evidence groups favor XERS today, and the comparison is rated Stable on stability: the leader is throwing conflicting signals. XERS lead: Stable — the AIQ differential has held near 25 points over 30 sessions.

Compare Absci Corporation and Xeris Biopharma Holdings, Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.

Currently unavailable

Performance over time

Price return from daily closes; distributions are not included.

ABSI
-31.5%
XERS
+580.0%

Price return comparison

Growth of $10,000, price only

ABSI $6,848 · XERS $68,000

Split-adjusted closes only. Distributions are excluded, which understates the return of any fund or stock that pays them.

Compare ABSI and XERS against another ticker

Open a multi-ticker workspace without changing this focused pair page.

Basic: 2 symbols·Explorer: 3 symbols·Pro and Premium: 5 symbols·Your limit: 2

AIQ Factor Divergence

Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.

ABSI advantage
0
XERS advantage
  • Quality26 vs 71
    XERS +45
  • Risk Resilience30 vs 55
    XERS +25
  • Momentum85 vs 98
    XERS +13

4 of 5 evidence groups favor XERS. XERS’s edge is concentrated in quality and risk resilience.

What changed since the last close

Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.

ABSI0 AIQ

Largest factor move: Quality -2, not enough on its own to move the overall score.

New signals

  • TSI Bearish Crossover — bearish, momentum, short horizon
XERS+1 AIQ

Largest factor move: Value +1

No signal started or stopped since the prior session; its 9 active signals are unchanged.

XERS's lead widened by 1 AIQ point in the latest session.

Deeper signal detail for each name lives on its own signals page — ABSI and XERS both carry a full feed there.

The central trade-off

XERS (Xeris Biopharma Holdings, Inc.): the stronger current systematic profile, led by quality and risk resilience.

ABSI (Absci Corporation): the counter-case, on analyst expectations — but at materially higher volatility, 126.6% against 110.3%.

The AIQ Score and Wall Street therefore point in different directions on this pair.

Which one fits your objective

The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.

Balanced

XERS

XERS on the overall AIQ Score, which weights Quality and Value most heavily.

Growth

XERS

XERS on combined revenue and EPS growth.

Value

Even

The two are level on Value.

Momentum

XERS

XERS on the Momentum factor, by 13 points.

Lower downside

XERS

XERS on Risk Resilience, by 25 points.

Analyst upside

ABSI

ABSI on implied upside to the consensus price target.

AIQ vs Wall Street

The model and the Street disagree here: AIQ favors XERS, analyst targets favor ABSI. That disagreement is the most useful thing on this page.

MeasureABSIXERSNote
Implied upside to target+71.6%-10%ABSI has more room
Target dispersion+6.9%+13.3%Lower is tighter analyst agreement
ConsensusBuyBuyContext, not a primary driver
Analysts covering127Higher coverage generally improves confidence

The two are measuring different things. The AIQ Score reads current fundamentals, valuation, trend and risk; analyst targets price forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something already priced in — it is worth resolving before acting on either.

Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.

AIQ Agreement Matrix

4 of 5 covered evidence groups favor XERS. A wide gap backed by one group is a weaker case than a narrow gap backed by five.

Evidence groupFavorsReading
AIQ ScoreXERS53 vs 78
FundamentalsXERSrevenue growth -4.4% vs 16.4%; EPS growth 9.5% vs 133.3%; TTM ROE -15.2% vs 23.1%; gross margin -26.5% vs 84.4%; operating margin -91.6% vs 12.7%
ValuationNot coveredNot covered
TechnicalsXERSPrice vs 50-day -12.5% vs 60.1%; vs 200-day 23.7% vs 112.8%
Risk ResilienceXERSRisk Resilience 30 vs 55
Analyst expectationsABSITarget upside 71.6% vs -10%

✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of ABSI and XERS and are excluded from the count.

AIQ Decision Stability

Stable

The conclusion rests on a wide gap and broad agreement. It is unlikely to turn on a single session.

  • The AIQ gap is wide at 25 points. (supports the conclusion holding)
  • 4 of 5 covered evidence groups point the same way. (supports the conclusion holding)
  • The lead has been steady session to session. (supports the conclusion holding)
  • The leader is throwing conflicting signals. (argues the conclusion is provisional)

Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on XERS.

How the comparison changed

120 daily snapshots · May 27 – Nov 13

XERS lead: Stable — the AIQ differential has held near 25 points over 30 sessions.

May 27ABSI leads above the line · XERS leads belowNov 13
Today
XERS +25
53 vs 78
7 sessions ago
XERS +22
55 vs 77
30 sessions ago
XERS +23
53 vs 76
90 sessions ago
XERS +14
57 vs 71

The lead has not changed hands in this window.

AIQ Signal Divergence

Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.

ABSIConflicted

2 bullish / 3 bearish / 1 neutral, conflicted

Only ABSI

  • Accumulation Pattern — bullish, volume, medium horizon (1.30x)
  • Beta Spike Warning — bearish, risk_regime, long horizon
  • MACD Histogram Expanding Bearish — bearish, momentum, short horizon
  • TSI Bearish Crossover — bearish, momentum, short horizon
XERSConflicted

6 bullish / 1 bearish / 2 neutral, conflicted

Only XERS

  • 52-Week High Proximity — bullish, risk_regime, long horizon (0.7%)
  • ADX Trend Strengthening — neutral, trend, medium horizon
  • EMA Ribbon Expansion Bullish — bullish, trend, medium horizon
  • Keltner Channel Breakout — bullish, volatility, short horizon
  • RSI Overbought — bearish, momentum, short horizon
  • TRIX Bullish Signal — bullish, momentum, short horizon
  • Uptrend Structure Active — bullish, trend, long horizon

Both carry 2 more signals that do not separate them: Golden Cross Active, ATR Expansion - Breakout Mode.

XERS leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.

Price vs model alignment

Whether the latest session's price move confirms what the model did over the same session, or contradicts it.

ABSINo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -7.5%, AIQ 0 points).

XERSNo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price +0.06%, AIQ +1 points).

What would flip this result

A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.

  1. 1ABSI closes the Quality gap — currently 45 points behind, the largest single contributor to XERS's edge.
  2. 2ABSI's Beta Spike Warning resolves — a bearish risk_regime rule currently active against it.
  3. 3XERS's conflicting signal state resolves bearish — it currently carries 6 bullish and 1 bearish rules at once.
  4. 4A market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

The full evidence

Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.

Fundamentals

XERS leads on balance
MetricABSIXERS
Revenue growth (YoY)-4.4%16.4%
EPS growth (YoY)9.5%133.3%
Gross margin-26.5%84.4%
Operating margin-91.6%12.7%
Return on equity (TTM)-15.2%23.1%
Debt to equity0.024.63

Performance

XERS leads 4 of 6 windows
MetricABSIXERS
1 week (5 sessions)-16.9%9.6%
1 month (20 sessions)2.4%61.6%
3 months (63 sessions)-8.5%95.5%
6 months (126 sessions)64.7%167%
Year to date142.1%112.2%
1 year (252 sessions)148.5%119.5%

Technicals

XERS has the stronger structure
MetricABSIXERS
RSI (14)4285.4
ADX (14)13.847
Price vs 50-day-12.5%60.1%
Price vs 200-day23.7%112.8%
Volatility (1M, annualized)126.6%110.3%

Risk

XERS is the more resilient
MetricABSIXERS
Beta3.280.07
Sharpe ratio1.581.67
Sortino ratio2.742.99
Max drawdown-42.8%-34.9%
Current drawdown-30.2%0%
Annualized volatility104.2%57%
Value at risk (95%)-8.2%-4.3%

Straight answers

Each answer is regenerated from the current snapshot, not written once and left to age.

Which is better, ABSI or XERS?

On the Algovestiq AIQ Score, XERS is the stronger of the two as of Nov 15, 2026, scoring 78 against ABSI's 53. The edge comes from quality and risk resilience. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.

Is ABSI or XERS the better buy right now?

XERS carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Stable — 4 of 5 covered evidence groups agree. A Stable rating means the gap is wide and the evidence is broad, so the conclusion is unlikely to turn on a single session.

Why does the AIQ Score favor XERS over ABSI?

The composite weights Quality, Value, Momentum and Risk Resilience. XERS leads Quality by 45 points; XERS leads Risk Resilience by 25 points; XERS leads Momentum by 13 points. Where the two split, the factor with the larger weight carries the result.

Which has more analyst upside, ABSI or XERS?

Analyst price targets imply +71.6% upside for ABSI and -10% for XERS, so the Street currently favors ABSI. That points the opposite way to the AIQ Score, which favors XERS. The two are measuring different things: the model reads current fundamentals, valuation, trend and risk; the Street is pricing forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something the analysts have already priced — it is the single most useful row on this page to investigate. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.

Which is better value, ABSI or XERS?

Neither name separates on the peer-relative Value factor. The two are level on Value. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.

Which has stronger growth, ABSI or XERS?

XERS on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.

Which has stronger momentum, ABSI or XERS?

XERS on the Momentum factor, by 13 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.

Which is riskier, ABSI or XERS?

XERS is the more resilient of the two, so the other name carries the higher downside risk. XERS on Risk Resilience, by 25 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.

Is ABSI more profitable than XERS?

XERS leads on the comparable margin measures — gross margin -26.5% vs 84.4%; operating margin -91.6% vs 12.7%; ttm roe -15.2% vs 23.1%.

Is XERS's lead over ABSI getting stronger or weaker?

XERS lead: Stable — the AIQ differential has held near 25 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has not changed hands in that window.

What would change the ABSI vs XERS verdict?

The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: ABSI closes the Quality gap — currently 45 points behind, the largest single contributor to XERS's edge; ABSI's Beta Spike Warning resolves — a bearish risk_regime rule currently active against it; XERS's conflicting signal state resolves bearish — it currently carries 6 bullish and 1 bearish rules at once; a market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

What do the current signals say about ABSI and XERS?

ABSI: 2 bullish / 3 bearish / 1 neutral, conflicted. XERS: 6 bullish / 1 bearish / 2 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on ABSI is Golden Cross Active (bullish, long horizon). On XERS it is Golden Cross Active (bullish, long horizon).

Compare ABSI and XERS with others

Continue your research

This page answers which of the two. These answer the questions on either side of it.

How this comparison is scored

The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.

The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.

How to use side-by-side comparison →

This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.